Quintiles Transnational Asia Enhances Services In China

RESEARCH TRIANGLE PARK, N.C., June 2 /PRNewswire/ -- Quintiles Transnational Corp. today announced that Quintiles Laboratories Asia (QLAB Asia) has amended its existing agreement with Peking Union Medical College Hospital (PUMCH) to enhance central laboratory services in China.

The new amended agreement with PUMCH enhances services for customers by allowing Quintiles central laboratory (QLAB) facilities in China to operate under the same standardized processes, controls and reporting mechanisms as other QLAB facilities. Under the new arrangement, QLAB facilities in China will have dedicated rooms for specimen management and analytical testing using Quintiles' core instruments and globally harmonized processes that follow global QLAB standard operating procedures and core quality standard.

Quintiles already operates the largest and most comprehensive central lab testing facility in Asia at its Singapore base and has been providing central lab services in China under the initial agreement with PUMCH signed in October 2003.

Anand Tharmaratnam, M.D., CEO of Quintiles Southeast Asia and QLAB Asia, said: "The new agreement represents true growth and quality standardization of our Asia central lab service. It consolidates our position as the most comprehensive central lab group in Asia and very nicely complements our clinical business, which is the largest pharmaceutical development group in Asia."

Alan Ong, Vice President and General Manager, QLAB Asia, said of the enhanced services: "QLAB Asia performed nearly a million tests in 2004, of which 400,000 tests were for China trials. We are excited that our new enhanced services will now allow our customers to participate in the growth of clinical trials in Asia, freed from the problems and difficulties of exporting blood samples out of China."

The Beijing facility will be managed by Susan Sun, who recently joined Quintiles.

The company also announced that QLAB in China will apply for accreditation from the College of American Pathologists (CAP) by early 2006. Currently QLAB facilities in Singapore; Atlanta, Ga., US; Edinburgh, Scotland; and Pretoria, SA, are all CAP certified.

About Quintiles Asia

Quintiles Asia has clinical development offices across seven countries in Southeast Asia. Since 1995 the Quintiles Asia clinical team in Southeast Asia has completed over 150 Phase II and III studies from 1,000 sites and recruited over 35,000 patients into international clinical trials. Its central lab operations in Singapore has serviced over 200 studies with samples shipped in from 15 Asia Pacific countries, making it the leading pharmaceutical development central lab service provider in the region.

About Quintiles Transnational

Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Headquartered near Research Triangle Park, North Carolina, Quintiles Transnational has offices in 50 countries and is the world's leading pharmaceutical services organization. For more information visit the company's Web site at http://www.quintiles.com .

Quintiles Transnational Corp.

CONTACT: Dick Jones, Media Relations, +1-919-998-2091, ormedia.info@quintiles.com ; or Greg Connors, Investor Relations,+1-919-998-2000, or invest@quintiles.com , both of Quintiles TransnationalCorp.

Back to news